Patents by Inventor Lars Terenius

Lars Terenius has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR THE DIAGNOSIS OF AMYLOID-ASSOCIATED DISEASES
    Publication number: 20220026446
    Abstract: The invention relates generally to methods for the diagnosis and/or prognosis of an amyloid-associated disease, methods of treating an amyloid-associated disease, and methods of identifying an agent for the treatment of an amyloid-associated disease, as well as related uses and kits of parts
    Type: Application
    Filed: April 1, 2019
    Publication date: January 27, 2022
    Applicant: AmyloiDia Sweden AB
    Inventors: Vladana VUKOJEVIC, Astrid GRÄSLUND, Jüri JARVET, Ann Tiiman, Rudolf RIGLER, Lars TERENIUS, Sebastian WÄRMLÄNDER
  • Peptide binding the KLVFF-sequence of amyloid-?
    Patent number: 7288523
    Abstract: The invention relates to compounds of formula (I) or (II), which are of interest especially for inhibition of polymerization of amyloid ? peptide, as model substances for synthesis of amyloid ? peptide-ligands, as tools for the identification of other organic compounds with similar functional properties and/or as ligands for detection of amyloid deposits using e.g., positron emission tomography (PET).
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: October 30, 2007
    Assignee: Neurochem (International) Limited
    Inventors: Christer Nordstedt, Jan Näslund, Johan Thyberg, Lars O. Tjernberg, Lars Terenius
  • Peptide binding the KLVFF-sequence of amyloid-beta
    Publication number: 20040157781
    Abstract: The invention relates to compounds of formula (I) or (II), which are of interest especially for inhibition of polymerization of amyloid &bgr; peptide, as model substances for synthesis of amyloid &bgr; peptide-ligands, as tools for the identification of other organic compounds with similar functional properties and/or as ligands for detection of amyloid deposits using e.g., positron emission tomography (PET).
    Type: Application
    Filed: November 26, 2003
    Publication date: August 12, 2004
    Applicant: Karolinska Innovations AB
    Inventors: Christer Nordstedt, Jan Naslund, Johan Thyberg, Lars O. Tjernberg, Lars Terenius
  • Peptide binding the KLVFF-sequence of amyloid-beta
    Publication number: 20020094957
    Abstract: The invention relates to compounds of formula (I) or (II), which are of interest especially for inhibition of polymerization of amyloid &bgr; peptide, as model substances for synthesis of amyloid &bgr; peptide-ligands, as tools for the identification of other organic compounds with similar functional properties and/or as ligands for detection of amyloid deposits using e.g., positron emission tomography (PET).
    Type: Application
    Filed: May 8, 2001
    Publication date: July 18, 2002
    Inventors: Christer Nordstedt, Jan Naslund, Johan Thyberg, Lars O. Tjernberg, Lars Terenius
  • Peptide binding the KLVFF-sequence of amyloid-&bgr;
    Patent number: 6331440
    Abstract: The invention relates to compounds of formula (I) or (II), which are of interest especially for inhibition of polymerization of amyloid &bgr; peptide, as model substances for synthesis of amyloid &bgr; peptide-ligands, as tools for the identification of other organic compounds with similar functional properties and/or as ligands for detection of amyloid deposits using e.g., positron emission tomography (PET).
    Type: Grant
    Filed: June 10, 1998
    Date of Patent: December 18, 2001
    Assignee: Karolinska Innovations AB
    Inventors: Christer Nordstedt, Jan Näslund, Johan Thyberg, Lars O. Tjernberg, Lars Terenius